Crown To Acquire StriVectin, Appoint Its President Chief Commercial Officer
StriVectin president Cori Aleardi will join Crown’s executive leadership team, helping to merge the businesses and drive growth across Crown’s brand portfolio, which includes PanOxyl acne wash, Blue Lizard Australian Sunscreen, the SkinPen microneedling device, and prescription skin creams.
You may also be interested in...
Inc. 5000 ranks the fastest-growing privately held companies in the US. With three-year growth of nearly 2,200%, Soapbox came in at No. 198 on the 2021 list, outpacing other beauty and personal-care companies that had enviable showings nevertheless in a year of unprecedented challenges.
Sales to Crown Labs didn't breach GSK's attention when it reported its Q1 results, with its consumer health discussion limited to general figures on regions and product categories. Pfizer offered even less about its consumer health operations and plans with its Q1 report.For Crown Labs, landing North American rights to Keri brand marks another step toward offering comprehensive skin care selection.
Private equity firm Catterton Partners augments its cosmeceutical portfolio with the acquisition of an early trailblazer across the cosmetics/pharmaceuticals frontier, StriVectin